HEAD-TO-HEAD COMPARISON OF TLL-018 AND TOFACITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: INTERIM RESULTS FROM A PHASE IIA STUDY

被引：2
|
作者：
Zeng, X. [1 ]
Wu, C. [1 ]
Hu, J. [2 ]
Liu, S. [3 ]
Jiang, Z. [4 ]
Li, J. [5 ]
Wang, X. [6 ]
Liu, J. [7 ]
Liang, C. [8 ]
Yang, G. [8 ]
机构：
[1] Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing, Peoples R China
[2] Pingxiang Peoples Hosp, Dept Rheumatol & Clin Immunol, Pingxiang, Peoples R China
[3] Zhengzhou Univ, Dept Rheumatol & Clin Immunol, Affiliated Hosp 1, Zhengzhou, Peoples R China
[4] Jilin Univ, Dept Rheumatol & Clin Immunol, Affiliated Hosp 1, Changchun, Peoples R China
[5] Zhuzhou Cent Hosp, Dept Rheumatol & Clin Immunol, Zhuzhou, Peoples R China
[6] Shanxi Med Univ, Dept Rheumatol & Clin Immunol, Hosp 2, Taiyuan, Shanxi, Peoples R China
[7] Jiujiang 1 Peoples Hosp, Dept Rheumatol & Clin Immunol, Jiujiang, Peoples R China
[8] Highlightll Pharma, Hangzhou, Peoples R China
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Rheumatoid arthritis; non biologic treatment and small molecules;
D O I：
10.1136/annrheumdis-2023-eular.7058
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
LB0001
引用
收藏
页码：200 / 200
页数：1
相关论文
共 50 条
  • [1] Head-to-Head Comparison of TLL-018 and Tofacitinib in Patients with Active Rheumatoid Arthritis: Final Results from a Phase IIa Study
    Zeng, Xiaofeng
    Wu, Chanyuan
    Hu, Jiankang
    Liu, Shengyun
    Jiang, Zhenyu
    Li, Jingyang
    Wang, Xiaoxia
    Liu, Ju
    Yuan, Chaofan
    Yang, Guang
    Liang, Chris
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1684 - 1686
  • [2] Treatment Comparison in Rheumatoid Arthritis: Head-to-Head Trials and Innovative Study Designs
    Favalli, Ennio Giulio
    Bugatti, Serena
    Biggioggero, Martina
    Caporali, Roberto
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [3] Head-to-head trial shows abatacept is as effective as adalimumab in patients with active rheumatoid arthritis
    Mayor, Susan
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (08) : 431 - 431
  • [4] Safety Profiles of Ixekizumab versus Adalimumab: 52-Week Results from a Head-to-Head Comparison in Patients with Active Psoriatic Arthritis
    Mease, Philip
    Smolen, Josef
    Kavanaugh, Arthur
    Nash, Peter
    Gallo, Gaia
    Liu-Leage, Soyi
    Sapin, Christophe
    Genovese, Mark
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [5] SAFETY PROFILES OF IXEKIZUMAB VERSUS ADALIMUMAB: 52-WEEK RESULTS FROM A HEAD-TO-HEAD COMPARISON IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Mease, P. J.
    Smolen, J. S.
    Kavanaugh, A.
    Nash, P.
    Gallo, G.
    Leage, S. Liu
    Sapin, C.
    Genovese, M. C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1698 - 1698
  • [6] Safety Profiles of Ixekizumab versus Adalimumab: 52-Week Results from a Head-to-Head Comparison in Patients With Active Psoriatic Arthritis
    Mease, Philip
    Smolen, Josef
    Kavanaugh, Arthur
    Nash, Peter
    Gallo, Gaia
    Liu-Leage, Soyi
    Sapin, Christophe
    Genovese, Mark
    Bessette, Louis
    [J]. JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1167 - 1167
  • [7] Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study
    Weinblatt, Michael E.
    Schiff, Michael
    Valente, Robert
    van der Heijde, Desiree
    Citera, Gustavo
    Zhao, Cathy
    Maldonado, Michael
    Fleischmann, Roy
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (01): : 28 - 38
  • [8] Head-to-Head Comparison of the Retention Rate of First Biologics in Elderly Patients with Rheumatoid Arthritis in Japanese Clinical Practice: Results from the Multicenter Biologic Registry
    Hayashi, Masatoshi
    Kanamono, Toshihisa
    Matsubara, Hiroyuki
    Kojima, Toshihisa
    Funahashi, Koji
    Takahashi, Nobunori
    Ishiguro, Naoki
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [9] HEAD-TO-HEAD COMPARISON OF SUBCUTANEOUS ABATACEPT VERSUS ADALIMUMAB ON BACKGROUND METHOTREXATE IN RHEUMATOID ARTHRITIS: BLINDED TWO-YEAR RESULTS FROM THE AMPLE STUDY
    Weinblatt, Michael E.
    Schiff, Michael H.
    Valente, Robert
    van der Heijde, Desiree
    Citera, Gustavo
    Elegbe, Ayanbola
    Maldonado, Michael A.
    Fleischmann, Roy
    [J]. RHEUMATOLOGY, 2014, 53 : 88 - 88
  • [10] Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study
    Smolen, Josef S.
    Burmester, Gerd-Ruediger
    Combe, Bernard
    Curtis, Jeffrey R.
    Hall, Stephen
    Haraoui, Boulos
    van Vollenhoven, Ronald
    Cioffi, Christopher
    Ecoffet, Cecile
    Gervitz, Leon
    Ionescu, Lucian
    Peterson, Luke
    Fleischmann, Roy
    [J]. LANCET, 2016, 388 (10061): : 2763 - 2774
12345